Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo

por Xiong, Le, Lin, Xiao-Min, Nie, Jun-Hua, Ye, Hai-Shan, Liu, Jia
Publicado 2021

Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects

por Lin, Xiao-Min, Shi, Xiao-Xiao, Xiong, Le, Nie, Jun-Hua, Ye, Hai-Shan, Du, Jin-Zi, Liu, Jia
Publicado 2021

Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations

por Lu, Meng-Di, Li, Hong, Nie, Jun-Hua, Li, Sheng, Ye, Hai-Shan, Li, Ting-Ting, Wu, Mo-Li, Liu, Jia
Publicado 2022

Frequently expressed glypican‐3 as a promising novel therapeutic target for osteosarcomas

por Nie, Jun‐Hua, Yang, Tao, Li, Hong, Li, Sheng, Li, Ting‐Ting, Ye, Hai‐Shan, Lu, Meng‐Di, Chu, Xiao, Zhong, Guo‐Qing, Zhou, Jie‐Long, Wu, Mo‐Li, Zhang, Yu, Liu, Jia
Publicado 2022

Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target

por Nie, Jun-Hua, Yang, Tao, Li, Hong, Ye, Hai-Shan, Zhong, Guo-Qing, Li, Ting-Ting, Zhang, Chi, Huang, Wen-Han, Xiao, Jin, Li, Zhi, He, Jian-Li, Du, Bo-Le, Zhang, Yu, Liu, Jia
Publicado 2021